Bloomberg traces how Amgen used genetic data from Iceland to guide its obesity drug research.
Recap by typeshit. Full story at Bloomberg.
A physio fielding years of peptide questions says strong studies are lacking, while noting that a lack of evidence doesn't prove they fail.
Up to half of participants in the two trials of the experimental drug ended up with only mild sleep apnea, per the post.
Nippard puts the two approved drugs on top for supervised weight loss and holds retatrutide at B-tier until it is approved.
Researchers in Denmark report pancreatic cells that naturally produce GLP-1, the hormone drugs like semaglutide are built to mimic.
The unapproved Lilly drug was confiscated in a dozen enforcement raids, part of a growing crackdown on gray-market retatrutide sellers.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Loading…